• A spin-off company from the laboratory of Dr. Gilles PAGES, University of Nice Cote d’Azur (Université de Nice Côte d’Azur) and the Institute for Research on Cancer and Aging (IRCAN)
• We leverage more than 20 years of internationally recognized cutting-edge research performed by the lab in cancer biology involving tumor angiogenesis and lymphangiogenesis
• A platform company with a portfolio of 3 secured patents and 2 expected patents
• A pipeline of antibodies against several validated targets in angiogenesis and lymphangiogenesis pathways
• Therapeutic applications: metastatic cancers and fibrotic disorders
• A team of seasoned scientists and biotech professionals
Company Details
- Employees
- 5
- Founded
- -
- Address
- 11, Rue De L'académie, C/o Semia,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.kekkan-biologics.com
- Keywords
- cancer, fibrosis, angiogenesis, lymphangiogenesis, kidney cancer, tRCC, translational research, platform company.
- HQ
- Strasbourg, Grand Est
Kekkan Biologics Questions
Kekkan Biologics's website is http://www.kekkan-biologics.com
Kekkan Biologics's LinkedIn profile is https://fr.linkedin.com/company/kekkan-biologics
Kekkan Biologics has
5 employees.
View email and phone details for 5
employees at Kekkan Biologics.
Kekkan Biologics's industry is
Biotechnology Research
Kekkan Biologics's top competitors are
Iome Bio,
Advesya,
Landmark Bioventures Ag,
G.clips Biotech,
Biper Therapeutics,
Roca Therapeutics,
Spima Therapeutics,
Elikya Therapeutics,
Carla Biotherapeutics,
Duhn Therapeutics.
Kekkan Biologics's categories are Biotechnology Research
Kekkan Biologics's founding year is 2022
